Recent Company News

• 09:22 AM ET Mar 30, 2026
  

  Shanghai Pharmaceuticals Holding releases sustainability report (HK$11.57, 0.00)

• 08:56 AM ET Mar 30, 2026
  

  Shanghai Pharmaceuticals Holding reports FY CAS net income attributable CNY5.73B vs FactSet CNY5.63B [8 est, CNY4.98-6.27B] (HK$11.57, 0.00)

• 11:42 PM ET Mar 22, 2026
  

  StreetAccount Summary: China Stocks reaching new 52-week highs/lows (55 total)

• 11:03 PM ET Mar 22, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (145 total)

• 11:11 PM ET Mar 03, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (139 total)

• 10:50 PM ET Mar 03, 2026
  

  StreetAccount Summary: China Stocks reaching new 52-week highs/lows (48 total)

• 05:06 AM ET Feb 04, 2026
  

  Shanghai Pharmaceuticals lists 30% stake in Sino-American Shanghai Squibb Pharmaceuticals for sale at reserve price of CNY1.02B (HK$11.75, 0.00)

• 11:39 PM ET Feb 02, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (122 total)

• 10:56 PM ET Feb 02, 2026
  

  StreetAccount Summary: China Stocks reaching new 52-week highs/lows (14 total)

• 10:38 PM ET Feb 01, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (98 total)